Vertex Pharmaceuticals Inc / Ma

Northwest & Ethical Investments L.P. VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

11,104

Value ($000)

5,034

Weight

0.1%

2020 Q4 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	5,034	0.1%	11,104	12/31/2025
2025 Q3	11/12/2025	5,998	0.1%	15,315	9/30/2025
2025 Q2	8/13/2025	6,718	0.2%	15,089	6/30/2025
2025 Q1	5/13/2025	7,058	0.2%	14,559	3/31/2025
2024 Q4	2/11/2025	11,204	0.3%	27,822	12/31/2024
2024 Q3	11/14/2024	12,390	0.3%	26,640	9/30/2024
2024 Q2	8/14/2024	11,270	0.3%	24,044	6/30/2024
2024 Q1	7/9/2025	10,051	0.3%	24,044	3/31/2024
2023 Q4	7/9/2025	17,437	0.5%	42,854	12/31/2023
2023 Q3	7/9/2025	13,393	0.5%	38,515	9/30/2023
2023 Q2	7/9/2025	7,635	0.2%	21,697	6/30/2023
2023 Q1	7/9/2025	5,008	0.2%	15,894	3/31/2023
2022 Q4	7/9/2025	1,260	0.0%	4,364	12/31/2022
2022 Q3	7/9/2025	3,809	0.2%	13,154	9/30/2022
2022 Q2	7/9/2025	3,808	0.1%	13,515	6/30/2022
2022 Q1	7/9/2025	3,527	0.1%	13,515	3/31/2022
2021 Q4	7/9/2025	4,752	0.1%	21,641	12/31/2021
2021 Q1	7/9/2025	1,411	0.0%	6,566	3/31/2021
2020 Q4	7/8/2025	620	0.0%	2,623	12/31/2020